These minor changes are often made solely to create the illusion that the patient requires a unique compounded formulation when, in reality, they do not. Whats particularly telling is that many compounding pharmacies are offering the same additives or minor adjustments to large numbers of patientsi.e., mass personalizationwhich clearly demonstrates a violation of FDA requirements for individualized compounding. FDA, Eli Lilly and Novo Nordisk Agree on Compounded GLP-1 Medications The FDA makes it clear: providers should not sell or market compounded GLP-1 medications like semaglutide and tirzepatide unless a patient has a legitimate, documented clinical need
When pharmaceutical manufacturers launch new brands, they increasingly face restrictions in payer coverage, which suppresses patient access, exposes patients to higher out-of-pocket costs, and impacts prescriber adoption
Niacinamide-specific side effects At the low doses used in compounded formulations (2 mg per mL), niacinamide side effects are extremely unlikely
This past week I had a full period - only lasted 1 day, but I was pretty excited
Stay tuned for the 3rd part in our series: : "Dentists Weigh In: Protecting Your Smile on GLP-1 Meds" to learn exactly what the experts recommend.